---
title: Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic
  stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G.
  99 and Ewing 2008 clinical trials
date: '2024-07-20'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39032218/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240721181857&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: The excess of acute toxicity associated with BuMel compared
  to VAI does not vary significantly with age, suggesting the feasibility of BuMel
  across all age ...'
disable_comments: true
---
CONCLUSION: The excess of acute toxicity associated with BuMel compared to VAI does not vary significantly with age, suggesting the feasibility of BuMel across all age ...